Armistice Capital, Llc

13F Holdings History for Kairos Pharma, LTD. - Common Stock, par value $0.001 per share (KAPA)

Symbol: KAPA on NYSE
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 885K shares
Security Ownership: 4.99%

Shares, Excluding Options vs Price

Value, Excluding Options

Armistice Capital, LLC ownership in Kairos Pharma, LTD. Common Stock, par value $0.001 per share (KAPA)

2025-08-14 - Armistice Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 885K shares of Kairos Pharma, LTD. Common Stock, par value $0.001 per share (KAPA). This represents 4.99% percent ownership of the company. In their previous filing dated 2025-05-15, ARMISTICE CAPITAL, LLC had reported owning 1.7M shares, indicating a decrease of -47.9% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Armistice Capital, LLC	4.99%	-50%	$1.04M	885K	-811,986	-47.9%	$1.18	13G/A	6/30/2025	14 Aug 2025 21:12:15
Armistice Capital, LLC	9.99%		$1.68M	1.7M			$0.99	13G	3/31/2025	15 May 2025 15:19:39

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025			-0.04%	$0	0	-1,404,000	-100%		Q2 2025
3/31/2025		0.04%	+0.04%	$1.31M	1.4M	+1,404,000	NEW	$0.94	Q1 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.